Who Semaglutide Weight Loss May be for Semaglutide may be appropriate for individuals who: Final determination is made during a medical consultation
A study of orforglipron (LY3502970) in adults with obesity or overweight (ATTAIN-1)
Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, ONeil PM, Rubino DM, Skovgaard D, MD, Wallenstein SOR, Garvey WT
The data currently available reflects findings on the individual components rather than this specific combination, with no established safety or efficacy for human or veterinary applications
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) Clinical trial demonstrating substantial mean weight loss with semaglutide 2.4 mg PubMed 5
Final thoughts: Managing semaglutide and constipation Constipation is a common but manageable side effect of semaglutide medications like Ozempic and Wegovy